Petri
Petri is a venture capital accelerator based in Boston, Massachusetts, specializing in early-stage companies and pre-seed capital investments. Founded in 2019, it focuses on startups in biotech applications, food, healthcare, industrial chemicals, and new materials, particularly within the realms of biology and engineering. Petri aims to support the commercialization of innovative technologies by investing up to $0.25 million in selected companies. In exchange for its participation in their program, Petri acquires 8.5% common stock of each company. The accelerator's program is structured around three-month sprints, culminating in a Demo Day presentation, which takes place either after three or nine months. Co-founded by members of a prominent venture firm, Petri benefits from a strong network within one of the world's leading biotech ecosystems, providing valuable resources to founders from around the globe.